Fortress Value Acquisition Corp V
FVAV · NASDAQ
About FVAV
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Feb 26, 2026
- Sector
- N/A
- Industry
- N/A
FVAV key statistics
- Market cap
- 362.82M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 81.36K
- Volume
- 72.01K
- Open price
- $10.09
- High today
- $10.04
- Low today
- $10.04
- 52 Week high
- $10.35
- 52 Week low
- $9.98
Fortress Value Acquisition Corp V (FVAV) at a glance
Fortress Value Acquisition Corp V (FVAV) last traded at $10.04, with a market cap of 362.82M and a price-to-earnings ratio of 0.00.
Volume so far is 72.01K shares, in line with the average of 81.36K shares a day.
Over the past year Fortress Value Acquisition Corp V has ranged from $9.98 to $10.35, and now sits 16% of the way up that range.
FVAV news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
Fortress Value Acquisition Corp. V Announces Closing of $250,000,000 Initial Public Offering
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.